DOW JONES21,413.44+469.93 2.24%
S&P 5002,526.90+56.40 2.28%
NASDAQ7,487.31+126.73 1.72%

Unity Biotechnology Q4 EPS $(0.39) Beats $(0.56) Estimate

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.56) by 30.36 percent. This is a 26.42 percent increase over losses of $(0.53) per share

Benzinga · 03/11/2020 20:14

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.56) by 30.36 percent. This is a 26.42 percent increase over losses of $(0.53) per share from the same period last year.